vs
费森尤斯医疗（FMS）与美盛公司（MOS）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是美盛公司的1.8倍（$5.5B vs $3.0B），费森尤斯医疗净利率更高（7.9% vs -17.5%，领先25.4%），美盛公司同比增速更快（5.6% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
美盛公司（The Mosaic Company）是总部位于美国佛罗里达州坦帕的化工企业，主营磷矿、钾矿开采及尿素采集，依托多元国际分销网络和旗下肥料业务板块生产销售农用肥料，是美国规模最大的钾肥、磷肥生产商。
FMS vs MOS — 直观对比
营收规模更大
FMS
是对方的1.8倍
$3.0B
营收增速更快
MOS
高出5.9%
-0.3%
净利率更高
FMS
高出25.4%
-17.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $3.0B |
| 净利润 | $434.2M | $-519.5M |
| 毛利率 | 27.4% | 11.5% |
| 营业利润率 | 11.7% | -3.4% |
| 净利率 | 7.9% | -17.5% |
| 营收同比 | -0.3% | 5.6% |
| 净利润同比 | 240.4% | -407.4% |
| 每股收益（稀释后） | — | $-1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSMOS
| Q4 25 | $5.5B | $3.0B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $3.0B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | $5.5B | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.7B |
净利润FMSMOS
| Q4 25 | $434.2M | $-519.5M | ||
| Q3 25 | — | $411.4M | ||
| Q2 25 | — | $410.7M | ||
| Q1 25 | — | $238.1M | ||
| Q4 24 | $127.6M | $169.0M | ||
| Q3 24 | — | $122.2M | ||
| Q2 24 | — | $-161.5M | ||
| Q1 24 | — | $45.2M |
毛利率FMSMOS
| Q4 25 | 27.4% | 11.5% | ||
| Q3 25 | — | 16.0% | ||
| Q2 25 | — | 17.3% | ||
| Q1 25 | — | 18.6% | ||
| Q4 24 | 25.0% | 10.7% | ||
| Q3 24 | — | 14.8% | ||
| Q2 24 | — | 14.0% | ||
| Q1 24 | — | 14.9% |
营业利润率FMSMOS
| Q4 25 | 11.7% | -3.4% | ||
| Q3 25 | — | 9.8% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | 5.1% | 3.5% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | 6.5% |
净利率FMSMOS
| Q4 25 | 7.9% | -17.5% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 13.7% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | 2.3% | 6.0% | ||
| Q3 24 | — | 4.3% | ||
| Q2 24 | — | -5.7% | ||
| Q1 24 | — | 1.7% |
每股收益（稀释后）FMSMOS
| Q4 25 | — | $-1.63 | ||
| Q3 25 | — | $1.29 | ||
| Q2 25 | — | $1.29 | ||
| Q1 25 | — | $0.75 | ||
| Q4 24 | — | $0.53 | ||
| Q3 24 | — | $0.38 | ||
| Q2 24 | — | $-0.50 | ||
| Q1 24 | — | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $276.6M |
| 总债务越低越好 | — | $4.3B |
| 股东权益账面价值 | $15.4B | $12.1B |
| 总资产 | $33.5B | $24.5B |
| 负债/权益比越低杠杆越低 | — | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资FMSMOS
| Q4 25 | $1.7B | $276.6M | ||
| Q3 25 | — | $153.3M | ||
| Q2 25 | — | $286.2M | ||
| Q1 25 | — | $259.2M | ||
| Q4 24 | $1.3B | $272.8M | ||
| Q3 24 | — | $301.6M | ||
| Q2 24 | — | $322.0M | ||
| Q1 24 | — | $336.7M |
总债务FMSMOS
| Q4 25 | — | $4.3B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | — | $3.3B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | — | $3.2B | ||
| Q1 24 | — | $3.2B |
股东权益FMSMOS
| Q4 25 | $15.4B | $12.1B | ||
| Q3 25 | — | $12.8B | ||
| Q2 25 | — | $12.4B | ||
| Q1 25 | — | $11.8B | ||
| Q4 24 | $17.0B | $11.5B | ||
| Q3 24 | — | $11.8B | ||
| Q2 24 | — | $11.7B | ||
| Q1 24 | — | $12.0B |
总资产FMSMOS
| Q4 25 | $33.5B | $24.5B | ||
| Q3 25 | — | $24.7B | ||
| Q2 25 | — | $24.3B | ||
| Q1 25 | — | $23.2B | ||
| Q4 24 | $36.3B | $22.9B | ||
| Q3 24 | — | $23.3B | ||
| Q2 24 | — | $22.6B | ||
| Q1 24 | — | $22.9B |
负债/权益比FMSMOS
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | $-56.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-405.7M |
| 自由现金流率自由现金流/营收 | — | -13.6% |
| 资本支出强度资本支出/营收 | — | 11.8% |
| 现金转化率经营现金流/净利润 | 6.67× | — |
| 过去12个月自由现金流最近4个季度 | — | $-534.6M |
8季度趋势，按日历期对齐
经营现金流FMSMOS
| Q4 25 | $2.9B | $-56.1M | ||
| Q3 25 | — | $228.5M | ||
| Q2 25 | — | $609.5M | ||
| Q1 25 | — | $42.9M | ||
| Q4 24 | $2.6B | $219.3M | ||
| Q3 24 | — | $312.9M | ||
| Q2 24 | — | $847.0M | ||
| Q1 24 | — | $-80.0M |
自由现金流FMSMOS
| Q4 25 | — | $-405.7M | ||
| Q3 25 | — | $-135.9M | ||
| Q2 25 | — | $304.9M | ||
| Q1 25 | — | $-297.9M | ||
| Q4 24 | — | $-74.8M | ||
| Q3 24 | — | $72.1M | ||
| Q2 24 | — | $513.1M | ||
| Q1 24 | — | $-463.0M |
自由现金流率FMSMOS
| Q4 25 | — | -13.6% | ||
| Q3 25 | — | -3.9% | ||
| Q2 25 | — | 10.1% | ||
| Q1 25 | — | -11.4% | ||
| Q4 24 | — | -2.7% | ||
| Q3 24 | — | 2.6% | ||
| Q2 24 | — | 18.2% | ||
| Q1 24 | — | -17.3% |
资本支出强度FMSMOS
| Q4 25 | — | 11.8% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 10.1% | ||
| Q1 25 | — | 13.0% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | 8.6% | ||
| Q2 24 | — | 11.9% | ||
| Q1 24 | — | 14.3% |
现金转化率FMSMOS
| Q4 25 | 6.67× | — | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | 20.20× | 1.30× | ||
| Q3 24 | — | 2.56× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -1.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
